| Secondary |
| Product Used For Unknown Indication |
37.5% |
| Drug Use For Unknown Indication |
34.4% |
| Nasopharyngitis |
9.4% |
| Somnolence |
6.3% |
| Anxiety |
3.1% |
| Cough |
3.1% |
| Insomnia |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
|
| Intentional Overdose |
18.2% |
| Unevaluable Event |
18.2% |
| Agitation |
9.1% |
| Euphoric Mood |
9.1% |
| Road Traffic Accident |
9.1% |
| Somnolence |
9.1% |
| Suicide Attempt |
9.1% |
| Vomiting |
9.1% |
| Weight Decreased |
9.1% |
|
| Concomitant |
| Cough |
12.2% |
| Prophylaxis |
10.5% |
| Product Used For Unknown Indication |
9.5% |
| Colorectal Cancer |
7.8% |
| Drug Use For Unknown Indication |
7.6% |
| Abdominal Pain |
5.9% |
| Wound Complication |
5.9% |
| Bronchitis |
4.6% |
| Nausea |
4.1% |
| Hypertension |
3.9% |
| Gastric Cancer |
3.7% |
| Non-small Cell Lung Cancer Metastatic |
3.4% |
| Non-small Cell Lung Cancer Stage Iv |
3.4% |
| Asthma |
2.7% |
| Breast Cancer |
2.7% |
| Pneumonia |
2.7% |
| Blood Pressure Abnormal |
2.4% |
| Nasopharyngitis |
2.4% |
| Pyrexia |
2.4% |
| Depression |
2.2% |
|
| Peripheral Motor Neuropathy |
11.3% |
| Hyperkalaemia |
9.9% |
| Pneumonia |
7.0% |
| No Adverse Event |
5.6% |
| Product Quality Issue |
5.6% |
| Stevens-johnson Syndrome |
5.6% |
| Upper Respiratory Tract Infection |
5.6% |
| Bronchitis |
4.2% |
| Drug Ineffective |
4.2% |
| Haemorrhage |
4.2% |
| Headache |
4.2% |
| Laryngitis |
4.2% |
| Malaise |
4.2% |
| Rash |
4.2% |
| Renal Failure Acute |
4.2% |
| Respiratory Failure |
4.2% |
| Ascites |
2.8% |
| Chest Pain |
2.8% |
| Cough |
2.8% |
| Gastrointestinal Haemorrhage |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
75.0% |
| Bronchitis Chronic |
12.5% |
| Chronic Obstructive Pulmonary Disease |
12.5% |
|
| Loss Of Consciousness |
75.0% |
| Headache |
25.0% |
|
